BioCentury
ARTICLE | Company News

Centocor's positive Remicade panel

July 12, 2000 7:00 AM UTC

The FDA's Arthritis Advisory Committee voted unanimously to recommend approval of Centocor's Remicade infliximab an anti-TNF-alpha antibody in combination with methotrexate to reduce joint damage in p...